byiShook Opinion
Oct 30, 2024 - 10:00
AbbVie easily beat third-quarter expectations and raised its earnings outlook for the year. AbbVie stock rose Wednesday. The post AbbVie Has A New Cash Cow As Humira Bows To Skyrizi In Third-Quarter Beat appeared first on Investor's Business Daily.
AbbVie easily beat third-quarter expectations and raised its earnings outlook for the year. AbbVie stock rose Wednesday.
The post AbbVie Has A New Cash Cow As Humira Bows To Skyrizi In Third-Quarter Beat appeared first on Investor's Business Daily.